Seattle Genetics

Biotech 2012 Kickoff Party: Investor Preview
TheStreet.com
Wed, 01/4/12 - 10:22 am
Celgene
Vivus
Dendreon
Gilead
Incyte
YM BioSciences
ONYX Pharmaceuticals
Seattle Genetics
Vertex
Amarin
Biomarin
Biogen Idec
Regeneron
Merck KGaA
Human Genome Sciences
Clovis Oncology
Roche
Ariad
Immunogen
Medivation
Geron
InterMune
Indenix
Amag Pharmaceuticals
Mesoblast
Arena
MannKind
Keryx
Spectrum Pharmaceuticals
6 'Coiled Spring' Biotech Stocks To Consider In 2012
Seeking Alpha
Tue, 01/3/12 - 12:48 pm
Amgen
Biogen Idec
Bristol-Myers Squibb
Celgene
Merck
Oncothyreon
Teva Pharmaceuticals
Vical
Seattle Genetics
Seattle Genetics: Innovative Biotech, Speculative Stock
Seeking Alpha
Mon, 01/2/12 - 11:24 am
Seattle Genetics
antibody-drug conjugate
What to Look For With Seattle Genetics in 2012
Motley Fool
Thu, 12/29/11 - 10:34 pm
Seattle Genetics
Adcetris
10 Biotech Stock Predictions for 2012
TheStreet.com
Tue, 12/20/11 - 11:13 am
Amgen
FDA
Oncothyreon
Merck KGaA
Vical
GSK
Seattle Genetics
M&A
Celgene
Biomarin
Amag Pharmaceuticals
Momenta
ONYX Pharmaceuticals
Cell Therapeutics
Roche
Aeterna Zentaris
Arena Pharmaceuticals
Vertex
Spectrum Pharmaceuticals
Seattle Genetics’ Adcetris Is Well Tolerated in Drug Combination
Bloomberg
Tue, 12/13/11 - 11:48 am
Adcetris
Seattle Genetics
Hodgkin's lymphoma
Five Biotech Stocks to Watch Going into Big Doctors' Meeting
Minyanville
Fri, 12/9/11 - 11:13 am
Seattle Genetics
ONYX Pharmaceuticals
Incyte
Celgene
Ariad Pharmaceuticals
December Catalysts for Drug and Biotech Stocks
Minyanville
Sat, 12/3/11 - 11:11 am
Pfizer
Aveo Pharmaceutical
Affymax
Amgen
Antares Pharma
Celgene
ONYX Pharmaceuticals
Seattle Genetics
Micromet
YM BioSciences
Regeneron
BioSante
Health Care's 5 Worst November Flops
Motley Fool
Thu, 12/1/11 - 11:42 am
Vertex
Seattle Genetics
Human Genome Sciences
Mako Surgical
Dendreon
Winners and Losers of Roche's Avastin Woes
Motley Fool
Tue, 11/29/11 - 06:48 pm
Roche
Avastin
breast cancer
Merck
GSK
Bristol-Myers Squibb
Eli Lilly
Teva Pharmaceuticals
Dr Reddy's
Watson
Seattle Genetics
Seattle Genetics Gains After Analyst Raises Sales Estimate for Cancer Drug
Bloomberg
Mon, 11/28/11 - 04:48 pm
Seattle Genetics
Hodgkin's lymphoma
Adcetris
11 Biotech Stocks With Bullish Short Trends
Seeking Alpha
Wed, 11/23/11 - 11:14 am
Biomarin
BioSpecifics Technologies
Complete Genomics
Incyte
Medivation
Insmed
Momenta
Questcor
Seattle Genetics
Sangamo BioSciences
XenoPort
4 Biotech Stocks Predictive Analysts Expect To Underperform
Seeking Alpha
Mon, 11/14/11 - 05:25 pm
Dendreon
Seattle Genetics
Sunesis
Alnylam
Healthcare Sector: Noteworthy Insider Buys And Sells
Seeking Alpha
Tue, 11/8/11 - 11:03 am
Alkermes
Bristol-Myers Squibb
Celgene
Gilead
Illumina
Inhibitex
JNJ
United Health
Seattle Genetics
Pharmasset
9 Biotech Stocks Being Snapped Up By Company Insiders
Seeking Alpha
Sun, 11/6/11 - 12:06 pm
Complete Genomics
Theravance
Ziopharm
Threshold Pharmaceuticals
Repros Therapeutics
MannKind
PharmAthene
Seattle Genetics
Corcept Therapeutics
Seattle Genetics beats Wall Street predictions for new cancer drug
Bizjournals.com
Fri, 11/4/11 - 09:31 am
Seattle Genetics
earnings
Seattle Genetics Inc. Third Quarter Earnings on Horizon
Yahoo/Wall St. Cheat Sheet
Mon, 10/31/11 - 11:51 am
earnings
Seattle Genetics
3 Biotech Takeover/LBO Targets With Bullish Short Trends
Seeking Alpha
Wed, 10/26/11 - 10:25 am
M&A
Alnylam
Seattle Genetics
Exelixis
Baker's Dozen Trying To Beat The Odds In Pancreatic Cancer
Seeking Alpha
Tue, 10/25/11 - 10:49 am
pancreatic cancer
Amgen
Celgene
Infinity
Oncolytics
Pharmacyclics
Immunomedics
Threshold Pharmaceuticals
Clovis Oncology
Novartis
Aduro BioTech
NewLink Genetics
Seattle Genetics
Bayer Schering
Astellas
Analyst: Seattle Genetics should outperform forecasts
bizjournals
Sat, 10/22/11 - 12:13 pm
Seattle Genetics
Adcetris
Hodgkin's lymphoma
anaplastic large-cell lymphoma

Pages